DLF Reports Marginal Decline in Q4 Profit as Revenue Drops 42 Board Recommends Rs 8 Dividend Biotech and Pharma Stocks Slide as Capital Rotates Toward Energy Sector Kadant Reports 18 Revenue Growth in Q1 Acquires Kadant Profil in 157M Deal Phoenix FENG Q3 2024 Earnings Preview What to Expect PureTech PRTC Q4 2024 Results Miss Estimates EPS 022 vs 020